| dc.contributor.author | Ojewale, Lucia Y | |
| dc.contributor.author | Mukumbang, Ferdinand C | |
| dc.date.accessioned | 2023-02-16T08:28:03Z | |
| dc.date.available | 2023-02-16T08:28:03Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | Ojewale, L. Y., & Mukumbang, F. C. (2023). Covid-19 vaccine hesitancy among Nigerians living with noncommunicable diseases: A qualitative study. BMJ open, 13(2), e065901. http://dx.doi.org/10.1136/bmjopen-2022-065901 | en_US |
| dc.identifier.issn | 2044-6055 | |
| dc.identifier.uri | http://dx.doi.org/10.1136/bmjopen-2022-065901 | |
| dc.identifier.uri | http://hdl.handle.net/10566/8428 | |
| dc.description.abstract | The discovery and subsequent manufacture
of various types of COVID-19 vaccines were considered a
breakthrough in the fight against the COVID-19 pandemic.
Initially, limited supplies of COVID-19 vaccines warranted
vulnerable populations such as people living with chronic
non-communicable diseases and the elderly to be
prioritised for vaccination. Nevertheless, the uptake of
the COVID-19 vaccines among these populations was
suboptimal. In this study, we aimed to describe the drivers
of COVID-19 vaccine hesitancy among people living with
chronic non-communicable diseases in Ibadan, Nigeria. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BMJ Publishing Group | en_US |
| dc.subject | Public health | en_US |
| dc.subject | Covid-19 | en_US |
| dc.subject | Nigeria | en_US |
| dc.subject | World Health Organization (WHO) | en_US |
| dc.subject | Diabetes | en_US |
| dc.title | Covid-19 vaccine hesitancy among Nigerians living with noncommunicable diseases: A qualitative study | en_US |
| dc.type | Article | en_US |
